| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 28 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 28 |
| 3 | ETOPOSIDE | 25 |
| 4 | METHOTREXATE | 24 |
| 5 | METHOTREXATE SODIUM | 24 |
| 6 | CISPLATIN | 16 |
| 7 | IFOSFAMIDE | 16 |
| 8 | IFOSFAMIDE FOR INJECTION | 16 |
| 9 | THIOTEPA | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 1 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 2 | THIOTEPA | 16 | 0.0016 |
| 3 | DACTINOMYCIN | 3 | 0.0014 |
| 4 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 5 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 6 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 7 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 8 | IFOSFAMIDE FOR INJECTION | 16 | 0.0007 |
| 9 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 47 |
| 1 | Topoisomerase Inhibitor [EPC] | 25 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 3 | Platinum-based Drug [EPC] | 21 |
| 4 | Corticosteroid [EPC] | 14 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 8 |
| 6 | Antirheumatic Agent [EPC] | 6 |
| 7 | Benzodiazepine [EPC] | 6 |
| 8 | Recombinant Human Growth Hormone [EPC] | 6 |
| 9 | Insulin Analog [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Topoisomerase Inhibitor [EPC] | 25 | 0.0003 |
| 2 | Recombinant Human Growth Hormone [EPC] | 6 | 0.0003 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 5 | Alkylating Drug [EPC] | 47 | 0.0002 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 8 | Sulfone [EPC] | 1 | 0.0001 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |